Package Leaflet: Information for the User
Cilostazol Aristo 50 mg tablets EFG
Cilostazol Aristo 100 mg tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Cilostazol Aristo belongs to a group of medicines known as phosphodiesterase type 3 inhibitors.
It has several actions, including the dilation of certain blood vessels and the reduction of the coagulant activity (aggregation) of certain blood cells, called platelets, in the blood vessels.
You have been prescribed cilostazol for "intermittent claudication". Intermittent claudication is the pain in the legs when walking, which is caused by insufficient blood supply to the legs. Cilostazol may help you increase the distance you can walk, as it improves blood circulation in the legs. Cilostazol is only recommended for patients whose symptoms have not improved sufficiently after making lifestyle changes (such as stopping smoking and exercising more) and after other appropriate interventions. It is important that you continue with the lifestyle changes you have made while taking cilostazol.
Do not take Cilostazol Aristo
Warnings and precautions
Before taking cilostazol, make sure your doctor knows:
During treatment with Cilostazol Aristo, make sure that
Children and adolescents
Cilostazol is not suitable for children.
Taking Cilostazol Aristo with other medicines
Before starting to take cilostazol, inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
You must specifically inform your doctor if you are taking medicines that are usually taken to treat painful and/or inflammatory conditions in the muscles or joints, as well as if you are taking medicines to reduce blood clotting. These medicines include:
If you are taking these medicines with cilostazol, your doctor may need to perform routine blood tests.
Certain medicines may interfere with the effect of cilostazol when taken together. They may increase the side effects of cilostazol or reduce its effectiveness. Cilostazol may have these same effects on other medicines. Before starting to take cilostazol, inform your doctor or pharmacist if you are taking:
If you are unsure whether this applies to the medicines you are taking, consult your doctor or pharmacist.
Before starting to take cilostazol, inform your doctor or pharmacist if you are taking medicines to treat high blood pressure, as cilostazol may have an additional blood pressure lowering effect.
If your blood pressure drops too low, you may experience an increased heart rate. These medicines include:
It may be possible to take these medicines with cilostazol.
Your doctor will decide if this is suitable for you.
Using Cilostazol Aristo with food and drink
You should take the cilostazol tablets 30 minutes before breakfast and dinner.
Always take the tablets with a glass of water.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
DO NOT TAKEcilostazol during pregnancy.
IT IS NOT RECOMMENDEDto take cilostazol during breast-feeding.
Driving and using machines
Cilostazol can cause dizziness. If you feel dizzy after taking cilostazol, DO NOTdrive or use any tools or machines and inform your doctor or pharmacist.
You may notice the benefits of taking cilostazol within 4-12 weeks of treatment. At 3 months of treatment, your doctor will assess your progress and may recommend that you stop taking cilostazol if the treatment effect is not sufficient.
Use in children and adolescents
Cilostazol is not suitable for children.
If you take more Cilostazol Aristo than you should
If you take more tablets than you should, you may experience symptoms such as severe headache, diarrhea, low blood pressure, and irregular heartbeats.
If you take more tablets than prescribed, contact your doctor or the nearest hospital immediately. Remember to take the pack with you so that it is clear what medicine you have taken.
If you forget to take Cilostazol Aristo
Do not worry if you forget to take a dose. Wait until the next dose and continue with your treatment as usual. DO NOTtake a double dose to make up for forgotten doses.
If you stop taking Cilostazol Aristo
If you stop taking cilostazol, the pain in your legs may return or worsen. Therefore, you should only stop taking cilostazol if you experience side effects that require urgent medical attention (see section 4) or if your doctor tells you to do so.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, cilostazol can cause side effects, although not everybody gets them.
If you experience any of the following side effects, you may need urgent medical attention. Stop taking cilostazol and contact a doctor or go to the nearest hospital immediately.
You should also inform your doctor immediately if you experience fever or sore throat. You may need to have blood tests; your doctor will decide on the treatment you should receive.
The following side effects have been observed in patients treated with cilostazol. If you experience them, you should inform your doctor immediately:
Very common side effects(may affect more than 1 in 10 people)
Common side effects(may affect up to 1 in 10 people)
Uncommon side effects(may affect up to 1 in 100 people)
Diabetic patients may be at a higher risk of eye bleeding.
Rare side effects(may affect up to 1 in 1,000 people)
The following side effects have been observed during treatment with cilostazol, but the frequency with which they occur is unknown:
If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es
By reporting side effects, you can help provide more information on the safety of this medicine.
This medicine does not require any special storage conditions.
Keep Cilostazol Aristo out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month stated.
Do not use this medicine if you notice visible signs of deterioration (e.g. discoloration).
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Cilostazol Aristo
The active substance is cilostazol. Each tablet contains 50 mg or 100 mg of cilostazol.
Other ingredients are corn starch, microcrystalline cellulose, calcium carmellose, hypromellose, and magnesium stearate.
Appearance and packaging
Appearance:
50 mg: White or almost white, round, smooth, beveled tablets, engraved with "E" on one side and "601" on the other.
100 mg: White or almost white, round, smooth, beveled tablets, engraved with "E" on one side and "602" on the other.
This product is available in packs of 28 (2x14) or 56 (4x14) tablets, packaged in PVC/PVdC and aluminum blisters in a cardboard box with the leaflet.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Aristo Pharma Iberia, S.L.
c/ Solana, 26
28850, Torrejón de Ardoz
Madrid, Spain
Manufacturer
EGIS Pharmaceuticals PLC
Bökényföldi út 118-120
Budapest
H-1165 Hungary
This medicine is authorized in the EEA member states with the following names:
Spain: Cilostazol Aristo 50 mg tablets EFG
United Kingdom: Cilostazol 50 mg tablets
Spain: Cilostazol Aristo 100 mg tablets EFG
United Kingdom: Cilostazol 100 mg tablets
Date of last revision of this leaflet: May 2017.
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/